4D Molecular Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
4D Molecular Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q3 2024.
  • 4D Molecular Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $1.2M, a 9.09% increase year-over-year.
  • 4D Molecular Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $4.8M, a 14.3% increase year-over-year.
  • 4D Molecular Therapeutics, Inc. annual Depreciation for 2023 was $4.4M, a 83.3% increase from 2022.
  • 4D Molecular Therapeutics, Inc. annual Depreciation for 2022 was $2.4M, a 60% increase from 2021.
  • 4D Molecular Therapeutics, Inc. annual Depreciation for 2021 was $1.5M, a 7.14% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.8M $1.2M +$100K +9.09% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $4.7M $1.2M +$100K +9.09% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $4.6M $1.2M +$200K +20% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.4M $1.2M +$200K +20% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $4.2M $1.1M +$600K +120% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $3.6M $1.1M +$600K +120% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $3M $1M +$600K +150% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.4M $1M +$700K +233% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $1.7M $500K +$100K +25% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $1.6M $500K +$100K +25% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.5M $400K $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.5M $300K $0 0% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $1.5M $400K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $1.5M $400K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.5M $400K +$100K +33.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.4M $300K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $400K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $400K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $300K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.